Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064593408> ?p ?o ?g. }
- W2064593408 endingPage "204" @default.
- W2064593408 startingPage "197" @default.
- W2064593408 abstract "In this multicenter, double-blind, placebo-controlled, randomized, four way cross-over proof-of-mechanism study, we tested the effect of the positive allosteric α7 nicotinic acetylcholine receptor (nAChR) modulator JNJ-39393406 in a key translational assay (sensory P50 gating) in 39 regularly smoking male patients with schizophrenia. All patients were clinically stable and JNJ-39393406 was administered as an adjunct treatment to antipsychotics. No indication was found that JNJ-39393406 has the potential to reverse basic deficits of information processing in schizophrenia (sensory P50 gating) or has a significant effect on other tested electrophysiological markers (MMN, P300 and quantitative resting EEG). Sensitivity analyses including severity of disease, baseline P50 gating, medication and gene variants of the CHRNA7 gene did not reveal any subgroups with consistent significant effects. It is discussed that potential positive effects in subgroups not present or not large enough in the current study or upon chronic dosing are possible, but unlikely to be developed. This article is part of a Special Issue entitled 'Cognitive Enhancers'." @default.
- W2064593408 created "2016-06-24" @default.
- W2064593408 creator A5013331848 @default.
- W2064593408 creator A5016626519 @default.
- W2064593408 creator A5018434240 @default.
- W2064593408 creator A5032531763 @default.
- W2064593408 creator A5033742518 @default.
- W2064593408 creator A5035411598 @default.
- W2064593408 creator A5043595820 @default.
- W2064593408 creator A5056848023 @default.
- W2064593408 creator A5067913949 @default.
- W2064593408 creator A5075236604 @default.
- W2064593408 creator A5081810610 @default.
- W2064593408 creator A5082722198 @default.
- W2064593408 creator A5085024791 @default.
- W2064593408 creator A5088365375 @default.
- W2064593408 date "2013-01-01" @default.
- W2064593408 modified "2023-10-18" @default.
- W2064593408 title "Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: A proof-of-mechanism study" @default.
- W2064593408 cites W1509900640 @default.
- W2064593408 cites W1513702727 @default.
- W2064593408 cites W1522538062 @default.
- W2064593408 cites W1532317254 @default.
- W2064593408 cites W1548399875 @default.
- W2064593408 cites W1570379376 @default.
- W2064593408 cites W1965386908 @default.
- W2064593408 cites W1968413560 @default.
- W2064593408 cites W1971032955 @default.
- W2064593408 cites W1975678648 @default.
- W2064593408 cites W1978382063 @default.
- W2064593408 cites W1980991473 @default.
- W2064593408 cites W1985093720 @default.
- W2064593408 cites W1987336202 @default.
- W2064593408 cites W1989866073 @default.
- W2064593408 cites W1993846632 @default.
- W2064593408 cites W1996121363 @default.
- W2064593408 cites W1997031801 @default.
- W2064593408 cites W1999309486 @default.
- W2064593408 cites W2002236839 @default.
- W2064593408 cites W2005627203 @default.
- W2064593408 cites W2011197443 @default.
- W2064593408 cites W2012654451 @default.
- W2064593408 cites W2016098801 @default.
- W2064593408 cites W2024338604 @default.
- W2064593408 cites W2024560338 @default.
- W2064593408 cites W2026402101 @default.
- W2064593408 cites W2026810208 @default.
- W2064593408 cites W2027977900 @default.
- W2064593408 cites W2028562300 @default.
- W2064593408 cites W2039576727 @default.
- W2064593408 cites W2045198631 @default.
- W2064593408 cites W2050161506 @default.
- W2064593408 cites W2051214582 @default.
- W2064593408 cites W2052103983 @default.
- W2064593408 cites W2052333829 @default.
- W2064593408 cites W2053725906 @default.
- W2064593408 cites W2057552760 @default.
- W2064593408 cites W2058494585 @default.
- W2064593408 cites W2062607123 @default.
- W2064593408 cites W2063778638 @default.
- W2064593408 cites W2066382872 @default.
- W2064593408 cites W2071228204 @default.
- W2064593408 cites W2071235040 @default.
- W2064593408 cites W2073642623 @default.
- W2064593408 cites W2074953815 @default.
- W2064593408 cites W2075183590 @default.
- W2064593408 cites W2078069463 @default.
- W2064593408 cites W2083540742 @default.
- W2064593408 cites W2083907790 @default.
- W2064593408 cites W2086835392 @default.
- W2064593408 cites W2090019512 @default.
- W2064593408 cites W2101530451 @default.
- W2064593408 cites W2114853842 @default.
- W2064593408 cites W2120431726 @default.
- W2064593408 cites W2121720045 @default.
- W2064593408 cites W2124533302 @default.
- W2064593408 cites W2124888321 @default.
- W2064593408 cites W2126866313 @default.
- W2064593408 cites W2126984402 @default.
- W2064593408 cites W2127153452 @default.
- W2064593408 cites W2130407782 @default.
- W2064593408 cites W2136354281 @default.
- W2064593408 cites W2138082287 @default.
- W2064593408 cites W2140383855 @default.
- W2064593408 cites W2144671685 @default.
- W2064593408 cites W2145814568 @default.
- W2064593408 cites W2150605429 @default.
- W2064593408 cites W2151643954 @default.
- W2064593408 cites W2155263358 @default.
- W2064593408 cites W2162845180 @default.
- W2064593408 cites W2167542986 @default.
- W2064593408 cites W2257525499 @default.
- W2064593408 cites W4251365796 @default.
- W2064593408 doi "https://doi.org/10.1016/j.neuropharm.2012.06.040" @default.
- W2064593408 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22766391" @default.
- W2064593408 hasPublicationYear "2013" @default.
- W2064593408 type Work @default.
- W2064593408 sameAs 2064593408 @default.